Technology Review Djibouti : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Djibouti .

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on December 13, 2025

Dec. 13, 2025

Free Spins No Deposit Casino | Real Money Online Casino No Deposit Bonus By Cafe Casino

GlobeNewswire

Dec. 13, 2025

환자 모집 가속화와 연구 혁신 강화에 나선 TrialWire®, Endpoints Clinical Trials Day NYC 2025 후원

GlobeNewswire

Dec. 13, 2025

New Crypto Coin Mutuum Finance (MUTM) Nears 100% of Phase 6 Allocation as Investor Activity Accelerates

GlobeNewswire

Dec. 13, 2025

データボルトAI (NASDAQ:…

GlobeNewswire

Dec. 13, 2025

Datavault AI Inc. (나스닥: DVLT), Datavault AI 적격 등재 주주 및 Scilex 보통주 보유자에게 Dream Bowl 밈 코인 토큰을 2025년 12월 24일 배포한다고 발표

GlobeNewswire

Dec. 13, 2025

Datavault AI Inc. (NASDAQ: DVLT) Mengumumkan Tarikh Pengagihan 24 Disember 2025 bagi Token Meme Coin Dream Bowl kepada Semua Pemegang Ekuiti Berdaftar yang Layak Datavault AI serta Pemegang Saham Biasa Scilex Holding Company

GlobeNewswire

Dec. 13, 2025

Datavault AI 宣布，将于 2025 年 12 月 24 日向所有符合条件的公司登记股权持有人，以及 Scilex Holding Company 的普通股持有人发放 Dream Bowl Meme Coin 代币

GlobeNewswire

Dec. 13, 2025

Datavault AI Inc. (NASDAQ: DVLT) 宣佈，將在 2025 年 12 月 24 日向所有合資格的 Datavault AI 登記股權持有人及 Scilex Holding Company 普通股持有人分發 Dream Bowl 迷因幣代幣

GlobeNewswire

Dec. 13, 2025

Fobi AI Announces Partial Revocation Order and Non-Brokered Private Placement

GlobeNewswire

Dec. 13, 2025

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

GlobeNewswire

Dec. 13, 2025

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

GlobeNewswire